Literature DB >> 30649281

Risk factors for subsequent work disability in patients with acute myocardial infarction.

Mo Wang1, Marjan Vaez1, Thomas Ernst Dorner2, Syed Rahman1, Magnus Helgesson1, Torbjörn Ivert3, Ellenor Mittendorfer-Rutz1.   

Abstract

BACKGROUND: Scientific knowledge on risk factors for work disability in terms of long-term sickness absence (SA) and disability pension (DP) following acute myocardial infarction (AMI) is limited. The study aimed to investigate socio-demographic, work-related and medical characteristics as risk factors for long-term SA (>90 days) and DP in patients with a first AMI.
METHODS: This is a population-based cohort study of 8199 individuals aged 19-60 years who had a first AMI during 2008-10 and were alive 30 days after AMI. Univariate and multivariable hazard ratios (HRs) and 95% confidence intervals (CIs) with regard to long-term SA and DP with a 3-year follow-up were estimated by Cox regression.
RESULTS: We found a higher risk of long-term SA and DP after AMI in women, those with lower education and previous SA (range of HRs: 1.29-7.34). Older age and being born in non-European countries were associated with a 2- to 3-fold higher risk of DP. Moreover, ST-elevation myocardial infarction (STEMI), musculoskeletal and common mental disorders (CMDs) were risk factors for long-term SA and DP, while diabetes mellitus and stroke were associated with a higher risk of DP (range of HRs: 1.12-2.98). Coronary artery bypass grafting (CABG) compared with percutaneous coronary intervention was associated with a 2-fold higher risk of work disability.
CONCLUSIONS: Older women, those with lower education and non-European immigrants had a higher risk of work disability after AMI, particularly permanent work disability. STEMI, CABG, diabetes mellitus, stroke, musculoskeletal disorders and CMDs provide important clinical information for work disability after AMI.
© The Author(s) 2019. Published by Oxford University Press on behalf of the European Public Health Association. All rights reserved.

Entities:  

Year:  2019        PMID: 30649281     DOI: 10.1093/eurpub/cky279

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  3 in total

1.  Atorvastatin combined with routine therapy on HIF-1, VEGF concentration and cardiac function in rats with acute myocardial infarction.

Authors:  Jingbin Yu; Lei Zhang; Hui Zhang
Journal:  Exp Ther Med       Date:  2020-01-27       Impact factor: 2.447

2.  Predicting Return to Work Following Myocardial Infarction: A Prospective Longitudinal Cohort Study.

Authors:  Weizhe Sun; Leila Gholizadeh; Lin Perry; Kyoungrim Kang
Journal:  Int J Environ Res Public Health       Date:  2022-06-30       Impact factor: 4.614

3.  Relationship between Admission Electrolyte Level and Short-term Prognosis of Patients with Acute ST-segment Elevation Myocardial Infarction after Percutaneous Coronary Intervention.

Authors:  Yaping Ren; Zhijie Yue; Xuewen Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-09       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.